--- title: "Hubei sets the first government-guided prices for brain–computer interface care" date: 2026-10-24 category: Brain–Computer Interface site: NeuroAI canonical: https://neuroai.site/a/na-brain-bci-medical-pricing language: en --- # Hubei sets the first government-guided prices for brain–computer interface care > Hubei priced three brain–computer interface (脑机接口) procedures on 31 March 2025, with invasive implantation set at RMB 6,552 per session under a provincial cap. A patient lies still in a Wuhan hospital bed and imagines moving a hand. Across the room, a machine reads the attempt and nudges a robotic arm into motion. For years in China, that scene belonged mostly to research labs and conference demos. Hospitals had no billing line for it, insurers had no reimbursement path, and families had no published price to weigh against hope. That changed in the spring of 2025, when one province decided the technology was mature enough to put a number on. ## Key takeaways - Hubei set China's first brain–computer interface medical prices on 31 March 2025 (Hubei Medical Insurance Bureau). - Invasive implantation is capped at RMB 6,552 (≈ US$923 / HK$7,207) per procedure (Hubei government). - Invasive removal is priced at RMB 3,139 (≈ US$442 / HK$3,453) per procedure (Hubei government). - Non-invasive adaptation is set at RMB 966 (≈ US$136 / HK$1,063) per session (Hubei government). - The national pricing guideline was issued on 12 March 2025, creating the line items (NHSA). - Prices are provincial maximums; providers may charge less but never more (Hubei Medical Insurance Bureau). ## Why a price matters A published price is a quiet but decisive step. Before a hospital can bill for a procedure, it needs a recognized service item, a coding path, and a reimbursement logic. Without those, even a working brain–computer interface (脑机接口) device stays stranded between a successful trial and a repeatable clinical service. The National Healthcare Security Administration (NHSA) moved first. On 12 March 2025 it issued the *Nervous System Medical Service Price Project Guideline (Trial)*, which carved out brain–computer interface as a distinct category rather than folding it into older neurology codes (NHSA, via gov.cn). The guideline created three forward-looking items: a non-invasive adaptation fee, and invasive implantation and removal fees. Hubei was the first province to act on that opening. On 31 March 2025 its Medical Insurance Bureau published concrete government-guided prices, the first such schedule in the country (Hubei government portal; Hubei Medical Insurance Bureau). ## What actually got priced The three items, each set as a provincial ceiling that cannot be exceeded, are: - **Invasive brain–computer interface implantation fee** — RMB 6,552 (≈ US$923 / HK$7,207) per procedure. - **Invasive brain–computer interface removal fee** — RMB 3,139 (≈ US$442 / HK$3,453) per procedure. - **Non-invasive brain–computer interface adaptation fee** — RMB 966 (≈ US$136 / HK$1,063) per session. The distinction is deliberate. Non-invasive systems sit on the scalp and need repeated calibration, so the guideline added an "adaptation" item to cover that tuning work. Invasive systems require neurosurgery, so they carry separate insertion and extraction items (NHSA). Officials framed the schedule as a maximum, with downward flexibility: hospitals may charge less, but not more (Hubei Medical Insurance Bureau). Jiang Xiaobing, director of neurosurgery at Wuhan Union Hospital, described the pricing as the policy guarantee that lets the technology move from the laboratory to the bedside (Hubei Daily, via Hubei government). Zhu Xiaoping, head of the price and procurement division at the Hubei Medical Insurance Bureau, said the charging path is now laid once the technology matures (CCTV). ## From demo to billed procedure The pricing does not license a device or approve a clinical use. It answers a narrower question: if a hospital already offers this service, what can it charge? That answer removes a long-standing blank. Industry analysts note that, before pricing, comprehensive invasive systems could carry total costs in the hundreds of thousands of yuan, and the absence of a billing code meant hospitals often ran such work as research rather than routine care (CE.cn, 2026). That matters because China has a sizeable addressable patient pool for motor and communication restoration. Analysts estimate the relevant domestic population runs into the hundreds of thousands, though no single official registry confirms a precise figure (CE.cn, 2026). A published price makes it possible to discuss scale without hand-waving. ## The cautious read A price is not a market. Hubei's schedule covers the procedure, not the device reimbursement, not inpatient stays, and not the long rehabilitation that often follows. Whether insurers pay, and how much, is a separate decision made by local funds. The national guideline explicitly says the charging path is ready "once the technology matures" — a hedge that leaves the timing to clinicians and regulators. There is also a strategic logic. By pricing insertion and extraction separately, and by naming non-invasive adaptation, the schedule quietly favors iterative, lower-risk deployment. Hospitals can start with calibration-heavy non-invasive work and only scale to surgery where evidence is strongest. ## Honest limitations The prices are Hubei's provincial ceilings, not a national tariff, and other provinces may set different numbers. The three items describe the procedure, not device cost, hospitalization, or rehabilitation, all of which are billed separately. Figures on the size of the patient pool come from industry analysts rather than an official registry. The schedule enables billing; it does not by itself expand insurance coverage or clinical approval. ## What readers can do now - **Operators:** map which of your existing neuro-rehab services already fit the three priced items, and prepare costing before local funds issue payment rules. - **Investors:** track how many provinces follow Hubei's lead in 2026; pricing spread is a cleaner adoption signal than press releases. - **Researchers:** document real per-patient procedure and calibration costs so the next pricing revision rests on evidence, not estimates. --- Published by NeuroAI (https://neuroai.site/) — https://neuroai.site/a/na-brain-bci-medical-pricing Free to quote with attribution and a link to the original.